New diabetes clinical trial: Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Published on: November 23, 2025 at 11:00PM
Conditions: Combined Hepatocellular-cholangiocarcinoma; Liver Neoplasms
Interventions: Drug: Cadonilimab; Drug: Capecitabine
Sponsors: Shanghai Zhongshan Hospital
Not yet recruiting
https://ift.tt/bcQipkY